Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewed
MRTX1133 is a potent non-covalent KRAS (G12C) inhibitor with tissue-specific activity
Abraham C. Sianoya, Yan Zuo, Cynthia V. Pagba…·Alemayehu Abebe Gorfe
This paper shows that MRTX1133, a non-covalent KRAS (G12D) inhibitor, also inhibits KRAS (G12C) with high affinity and suppresses MAPK signaling in pancreatic cancer cells but not lung cancer cells.
5 citationstop 1%